Klára Werling

541 total citations
43 papers, 315 citations indexed

About

Klára Werling is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Klára Werling has authored 43 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 29 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Klára Werling's work include Liver Disease Diagnosis and Treatment (27 papers), Hepatitis C virus research (20 papers) and Liver Disease and Transplantation (14 papers). Klára Werling is often cited by papers focused on Liver Disease Diagnosis and Treatment (27 papers), Hepatitis C virus research (20 papers) and Liver Disease and Transplantation (14 papers). Klára Werling collaborates with scholars based in Hungary, United States and Germany. Klára Werling's co-authors include Zsuzsa Schaff, András Kiss, Ilona Kovalszky, Gábor Lendvai, Katalin Borka, Tatjana Reić, Rob Bielen, Jeffrey V. Lazarus, Heino Stöver and Geert Robaeys and has published in prestigious journals such as PLoS ONE, Journal of Hepatology and Medicine.

In The Last Decade

Klára Werling

38 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klára Werling Hungary 9 154 115 94 59 36 43 315
Chung‐Bao Hsieh Taiwan 8 88 0.6× 151 1.3× 110 1.2× 179 3.0× 54 1.5× 13 396
Christoph Antoni Germany 10 269 1.7× 240 2.1× 71 0.8× 49 0.8× 12 0.3× 32 405
Katsumoto Kato Japan 12 92 0.6× 109 0.9× 138 1.5× 38 0.6× 22 0.6× 30 345
Serag Esmat Egypt 9 120 0.8× 63 0.5× 86 0.9× 19 0.3× 19 0.5× 17 248
Hannah M. Lee United States 11 286 1.9× 254 2.2× 39 0.4× 69 1.2× 22 0.6× 24 405
Masami Kuniyoshi Japan 9 239 1.6× 118 1.0× 63 0.7× 56 0.9× 10 0.3× 13 428
Yolanda Martínez Germany 9 106 0.7× 75 0.7× 28 0.3× 140 2.4× 42 1.2× 15 315
L. Bridoux‐Henno France 12 134 0.9× 82 0.7× 103 1.1× 19 0.3× 20 0.6× 21 290
Zunirah Ahmed United States 9 239 1.6× 190 1.7× 61 0.6× 57 1.0× 33 0.9× 25 385

Countries citing papers authored by Klára Werling

Since Specialization
Citations

This map shows the geographic impact of Klára Werling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klára Werling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klára Werling more than expected).

Fields of papers citing papers by Klára Werling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klára Werling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klára Werling. The network helps show where Klára Werling may publish in the future.

Co-authorship network of co-authors of Klára Werling

This figure shows the co-authorship network connecting the top 25 collaborators of Klára Werling. A scholar is included among the top collaborators of Klára Werling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klára Werling. Klára Werling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Werling, Klára, et al.. (2025). Cumulative Effect of Metabolic Factors on Hepatic Steatosis. Diagnostics. 15(18). 2406–2406.
2.
Bérczi, Viktor, et al.. (2025). Construction of a Compound Model to Enhance the Accuracy of Hepatic Fat Fraction Estimation with Quantitative Ultrasound. Diagnostics. 15(2). 203–203. 1 indexed citations
3.
Dezső, Katalin, et al.. (2025). A SPOCK1 fehérje szerepe a máj egészséges és kóros működéseiben. Orvosi Hetilap. 166(3). 82–89.
4.
Miheller, Pál, et al.. (2023). A poszt-COVID-szindrómával diagnosztizált betegek leggyakoribb gastrointestinalis eltérései. Orvosi Hetilap. 164(31). 1206–1212. 2 indexed citations
5.
Werling, Klára, Béla Hunyady, Mihály Makara, et al.. (2022). Hepatitis C Screening and Treatment Program in Hungarian Prisons in the Era of Direct Acting Antiviral Agents. Viruses. 14(2). 308–308. 3 indexed citations
6.
Lendvai, Gábor, András Kiss, Klára Werling, et al.. (2018). Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis. Pathology & Oncology Research. 26(1). 3–15. 74 indexed citations
7.
Lendvai, Gábor, Benedek Gyöngyösi, Klára Werling, et al.. (2018). MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma. Pathology & Oncology Research. 25(3). 1103–1109. 8 indexed citations
8.
Bielen, Rob, Klára Werling, Tatjana Reić, et al.. (2018). Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries. Harm Reduction Journal. 15(1). 25–25. 55 indexed citations
9.
Reszegi, Andrea, László Szilák, Klára Werling, et al.. (2018). Syndecan-1 inhibits early stages of liver fibrogenesis by interfering with TGFβ1 action and upregulating MMP14. Matrix Biology. 68-69. 474–489. 30 indexed citations
10.
Hunyady, Béla, Judit Gervain, Gábor Horváth, et al.. (2018). [Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 22 September 2017].. PubMed. 159(Suppl 1). 3–23. 2 indexed citations
11.
Hunyady, Béla, Judit Gervain, Gábor Horváth, et al.. (2017). A hepatitis C-vírus-fertőzés szűrése, diagnosztikája, antivirális terápiája, kezelés utáni gondozása. Magyar konszenzusajánlás. Érvényes: 2017. = Screening, diagnosis, treatment, and follow up of hepatitis C virus related liver disease. National consensus guideline in Hungary from 22 September 2017 szeptember 22-től. 4 indexed citations
12.
Hunyady, Béla, Judit Gervain, Gábor Horváth, et al.. (2017). A hepatitis C-vírus-fertőzés szűrése, diagnosztikája, antivirális terápiája, kezelés utáni gondozása. Magyar konszenzusajánlás. Érvényes: 2016. október 15-től. Orvosi Hetilap. 158(Supplement 1). 3–22. 3 indexed citations
13.
Liang, Tiebing, Mouhamad Alloosh, Lauren N. Bell, et al.. (2015). Liver injury and fibrosis induced by dietary challenge in the Ossabaw miniature Swine. Purdue e-Pubs (Purdue University System). 3 indexed citations
14.
Liang, Tiebing, Mouhamad Alloosh, Lauren N. Bell, et al.. (2015). Liver Injury and Fibrosis Induced by Dietary Challenge in the Ossabaw Miniature Swine. PLoS ONE. 10(5). e0124173–e0124173. 21 indexed citations
15.
Werling, Klára, et al.. (2009). Effect of Liver Steatosis on Therapeutic Response in Chronic Hepatitis C Virus Genotype 1 Infected Patients in Hungary. Pathology & Oncology Research. 16(2). 149–157. 5 indexed citations
16.
Tornai, István, Judit Gervain, Gábor Horváth, et al.. (2005). A pegilált interferon-alfa-2a-és ribavirinkezelés hatékonysága krónikus C-vírus-hepatitises betegeken - Az első hazai tapasztalatok egy multicentrikus, nyílt, prospektív vizsgálat alapján. Repository of the Academy's Library (Library of the Hungarian Academy of Sciences). 2 indexed citations
17.
Németh, Andrea H., et al.. (2005). Gastrointestinal Manifestations of Common Variable Immunodeficiency Diagnosed by Video- and Capsule Endoscopy. Endoscopy. 37(6). 603–604. 4 indexed citations
18.
Werling, Klára, et al.. (2001). Hepatocyte proliferation and cell cycle phase fractions in chronic viral hepatitis C by image analysis method. European Journal of Gastroenterology & Hepatology. 13(5). 489–493. 7 indexed citations
19.
Werling, Klára, et al.. (2000). Effect of hepatitis C virus on hepatocyte proliferation and DNA ploidy in patients with chronic hepatitis C. Zeitschrift für Gastroenterologie. 38(7). 553–558. 6 indexed citations
20.
Somogyi, Anikó, et al.. (1996). Treatment of drug-induced bone marrow suppression with recombinant human granulocyte/monocyte colony stimulating factor.. PubMed. 15(2). 119–24. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chung‐Bao Hsieh Breakdown of academic impact, for papers by Christoph Antoni Breakdown of academic impact, for papers by Katsumoto Kato Breakdown of academic impact, for papers by Serag Esmat Breakdown of academic impact, for papers by Hannah M. Lee Breakdown of academic impact, for papers by Masami Kuniyoshi Breakdown of academic impact, for papers by Yolanda Martínez Breakdown of academic impact, for papers by L. Bridoux‐Henno Breakdown of academic impact, for papers by Zunirah Ahmed
Rankless by CCL
2026